Structural biologist Yang Gao receives a five-year National Institutes of Health grant to detail how complex protein chains replicate DNA and fix errors on the fly. What they find could help treat genomic disease, including cancer.
Researchers at Rice University and Baylor College of Medicine develop an antibody conjugate called BonTarg that delivers drugs to bone tumors and inhibits metastasis.
Rice University chemist Julian West has won a five-year, $1.8 million National Institutes of Health grant to advance his lab’s efforts to simplify the synthesis of organic chemicals.
The little things of life mean a great deal to Julea Vlassakis, who will bring her study of protein complexes and their role in cancer proliferation to Rice University this year.
Rice University neurobiologist Rosa Uribe has won a five-year, $2 million R01 grant from the National Institutes of Health to study how the enteric nervous system develops.
B.J. Fregly, a professor of mechanical engineering and bioengineering and a CPRIT Scholar in Cancer Research, has been named a fellow of the American Society of Mechanical Engineers (ASME).
Researchers from Rice University and Baylor College of Medicine are part of a national effort to accelerate genome-editing research and develop gene-editing technologies and therapies.
A mutation that replaces a single amino acid in a potent tumor-suppressing protein makes it prone to nucleating amyloid fibrils implicated in many cancers as well as neurological diseases.
Rice bioengineers harness the CRISPR/Cas9 system to program histones, the support proteins that wrap up and control human DNA, to manipulate gene activation and phosphorylation. The new technology enables innovative ways to find and manipulate genes and pathways responsible for diseases.